PCOS (Polycystic Ovary Syndrome): How to Prep for Your First Visit

What PCOS Actually Is (and Why Diagnosis Takes Time)

PCOS is a hormone-driven metabolic condition, not simply an ovarian structural problem. Excess androgen production disrupts follicle maturation, stalls ovulation, and creates a feedback loop that raises insulin and luteinizing hormone (LH) further. The 2023 international evidence-based PCOS guideline, developed across 71 organizations in 37 countries, confirms that PCOS remains a diagnosis of exclusion requiring systematic ruling-out of thyroid disease, hyperprolactinemia, congenital adrenal hyperplasia, and androgen-secreting tumors before the label is applied. [1]

The Rotterdam Criteria in Plain Language

The Rotterdam criteria, established in 2003 and reaffirmed in subsequent guidelines, require at least two of these three features: oligo-ovulation or anovulation (fewer than 8 periods per year or cycles longer than 35 days), clinical or biochemical hyperandrogenism (acne, hirsutism, elevated serum testosterone), and polycystic ovarian morphology on ultrasound (20 or more follicles per ovary, or ovarian volume above 10 mL on either side). [2]

You can have PCOS without visible cysts. You can have cysts without PCOS. That distinction confuses patients and sometimes clinicians alike.

Why the Diagnostic Process Feels Slow

Reaching a confirmed diagnosis takes an average of two years and three clinician visits in the United States, according to survey data published in the Journal of Clinical Endocrinology and Metabolism. [3] The delay reflects overlapping symptoms with thyroid disorders, the normalization of irregular periods, and variable laboratory reference ranges across labs. Coming prepared collapses that timeline.

Building Your Symptom Log Before the Appointment

Bring a written record. Your provider needs pattern data, not memories. A 90-day minimum is the practical floor for spotting cycle irregularity, but longer is better.

What to Record in Your Menstrual Calendar

Log the start date, end date, and flow intensity (light, moderate, heavy) for every period. Note any spotting between cycles. Count the days between each cycle start. The Endocrine Society's 2023 guideline defines oligomenorrhea as fewer than 8 cycles per year or any cycle longer than 35 days, so even one or two data points outside that range deserve documentation. [4]

Free apps (Clue, Flo) export cycle summaries as PDFs. Print one and bring it.

Tracking Androgen-Related Symptoms

Note the approximate date you first noticed each symptom: facial or body hair growth, scalp hair thinning, persistent acne on the jawline or chest, and skin darkening in neck folds or underarms (acanthosis nigricans, a marker of insulin resistance). Photograph areas of hirsutism at consistent lighting over several months. Clinicians use the modified Ferriman-Gallwey score to quantify hirsutism; a score of 4 to 6 or higher, depending on ethnicity, indicates clinically significant androgen excess. [5]

Weight, Energy, and Mood Patterns

Record your weight at the same time of day weekly. Note energy crashes, especially after carbohydrate-rich meals, since postprandial fatigue is a common but under-reported symptom of insulin resistance. Up to 70% of women with PCOS have measurable insulin resistance regardless of body weight, including lean women. [6] Sleep disruption and mood changes are also worth logging; PCOS is independently associated with a 2.4-fold increased odds of depression compared with women without the condition. [7]

The Lab Panel You Should Request

Most primary care visits for irregular periods generate a basic hormone screen. That screen is rarely complete enough for PCOS workup. Ask your ordering provider to include every marker on this list at the initial draw.

Reproductive and Androgen Hormones

Request serum LH and FSH (drawn on cycle days 2 to 5 if cycles occur), total testosterone, free testosterone or free androgen index, sex hormone-binding globulin (SHBG), DHEA-S, and 17-hydroxyprogesterone (drawn in the follicular phase, ideally before 8 a.m., to screen for late-onset congenital adrenal hyperplasia). [8] The Endocrine Society guideline recommends measuring total testosterone using extraction and chromatography-based assays rather than direct immunoassay alone, because direct assays are unreliable at the low-end concentrations typical of female serum. [4]

Metabolic Markers

Request fasting insulin and fasting glucose together. Calculate HOMA-IR (fasting insulin × fasting glucose / 405 in US units); a value above 2.0 suggests insulin resistance, and above 2.5 is clinically significant in most published thresholds. [9] Add HbA1c, a full fasting lipid panel, and a comprehensive metabolic panel. Women with PCOS have roughly twice the age-adjusted risk of type 2 diabetes compared with matched controls, based on a 2019 meta-analysis of 24 studies covering 117,613 women. [10]

Thyroid and Prolactin

TSH and prolactin rule out two common mimics. Hypothyroidism raises SHBG and alters cycle regularity; hyperprolactinemia suppresses GnRH pulsatility and mimics anovulation. Both are treatable causes of irregular periods that must be excluded before attributing the picture to PCOS. [1]

What Your Provider Will Examine

Expect a focused physical exam covering blood pressure, BMI, waist circumference, and targeted skin findings. Your provider will look for acne distribution, hirsutism pattern, acanthosis nigricans at the nape, axillae, and groin, and alopecia pattern at the crown. A pelvic ultrasound is often ordered but is not required if you already meet two of the other Rotterdam criteria. [2]

Transvaginal ultrasound gives better resolution than transabdominal ultrasound for follicle counting. If you have not been sexually active, a transabdominal approach is used instead, and the follicle-count threshold of 20 per ovary may be harder to achieve technically. Tell your provider before the appointment so imaging logistics can be arranged.

First-Line Treatment Options to Know Before You Walk In

Understanding the menu of options lets you ask specific questions rather than absorbing information passively. No single treatment fits all phenotypes; your provider will prioritize based on your chief complaint (irregular cycles, fertility, hirsutism/acne, or weight/metabolic health).

Lifestyle Intervention

A 5 to 10% reduction in body weight improves ovulation frequency, lowers androgen levels, and improves insulin sensitivity in overweight and obese women with PCOS, according to a Cochrane review of lifestyle interventions in PCOS. [11] The composition of the diet matters less than the calorie deficit; low-glycemic-index and Mediterranean-style diets both show benefit in small trials, but adherence is the limiting factor. Resistance training two to three times per week adds independent benefit on insulin sensitivity beyond what aerobic exercise alone produces. [12]

Metformin

Metformin remains the most prescribed insulin sensitizer in PCOS outside of pregnancy. Starting doses of 500 mg twice daily, titrated over four to eight weeks to 1,000 to 2,000 mg/day, reduce fasting insulin, lower androgen levels modestly, and improve cycle regularity. [13] The 2023 international PCOS guideline recommends metformin as an adjunct to lifestyle intervention in adolescents and adults with PCOS who have metabolic risk factors, regardless of BMI. [1] Extended-release formulations reduce the gastrointestinal side effects that cause early discontinuation.

Combined Oral Contraceptives

Combined oral contraceptives (COCs) are the standard pharmacologic treatment for cycle regulation and androgen suppression in women not pursuing pregnancy. COCs raise SHBG, which binds free testosterone, and suppress LH-driven androgen production. The Endocrine Society recommends COCs as first-line for menstrual irregularity and hirsutism in PCOS. [4] Anti-androgen add-ons (spironolactone 50 to 100 mg/day, or flutamide) are added when COCs alone do not adequately control hirsutism after six months.

GLP-1 Receptor Agonists

GLP-1 receptor agonists are used off-label in PCOS for weight reduction and insulin sensitization. In the STEP-1 trial (N=1,961), semaglutide 2.4 mg subcutaneously once weekly produced 14.9% mean body-weight loss at 68 weeks versus 2.4% with placebo (P<0.001). [14] Women with PCOS and a BMI of 27 or above with a weight-related comorbidity may be candidates for semaglutide or liraglutide as part of a broader metabolic management plan, though PCOS-specific phase 3 trial data are still being collected.

A 2023 randomized controlled trial (N=150) published in Frontiers in Endocrinology found that liraglutide 1.8 mg daily for 12 weeks reduced fasting insulin by 28.4%, lowered total testosterone by 19.3%, and improved menstrual regularity in 58% of participants with PCOS compared with 31% in the metformin-only group (P<0.05). [15]

Fertility-Directed Treatments

If pregnancy is the goal, first-line ovulation induction in PCOS is letrozole 2.5 to 7.5 mg/day on cycle days 3 to 7. The NEJM-published PCOSACT trial (N=750) showed letrozole produced live birth rates of 27.5% versus 19.1% for clomiphene citrate (P=0.007), establishing letrozole as the preferred first-line agent despite its off-label status in the United States for this indication. [16]

Questions to Ask at Your First Appointment

Arrive with a written list. Providers work faster and more thoroughly when patients direct the conversation with specific questions.

The following question framework covers the four domains most patients leave the first visit without clarity on:

Diagnosis confidence. Ask: "Do I meet two of the three Rotterdam criteria, or is this still a working diagnosis? Which criteria am I missing?" This forces explicit documentation in your chart.

Metabolic risk. Ask: "What is my HOMA-IR today, and at what threshold would you recommend adding metformin or a GLP-1 agonist?" A provider who cannot answer in numbers is working from intuition rather than protocol.

Fertility timeline. Ask: "If I want to conceive in the next 12 months, what ovulation induction protocol would you start with, and what is the expected cumulative live birth rate after three cycles?" The PCOSACT data give a concrete benchmark: 27.5% per cycle with letrozole. [16]

Follow-up schedule. Ask: "How often do you recheck testosterone, fasting insulin, and HbA1c once treatment starts, and what changes would prompt a switch in protocol?" Standard practice in metabolic PCOS management involves repeat labs at 3 months after any medication change. [1]

Understanding Your Risk Profile Beyond Reproduction

PCOS is not a purely reproductive diagnosis. The long-term metabolic burden is substantial and guides how aggressively a provider should treat even asymptomatic metabolic findings.

Cardiovascular and Metabolic Risk

Women with PCOS have a 2-fold increased prevalence of metabolic syndrome compared with age-matched controls, based on a meta-analysis of 30 studies. [17] The American Heart Association notes that insulin resistance, dyslipidemia, and hypertension cluster in PCOS and may accelerate cardiovascular risk independent of obesity. [18] At your first visit, ask for a 10-year ASCVD risk score calculation if you are 30 or older or have more than one metabolic comorbidity.

Endometrial Cancer Risk

Chronic anovulation leads to unopposed estrogen stimulation of the endometrium. Women with PCOS who go more than three months without a period should receive progestin-induced withdrawal bleeds or use a COC to prevent endometrial hyperplasia. A population-based cohort study found a 2.7-fold increased risk of endometrial cancer in women with PCOS versus matched controls. [19]

Mental Health Screening

The 2023 international PCOS guideline formally recommends screening for anxiety and depression at every PCOS-related clinical encounter, using validated tools such as the PHQ-9 and GAD-7. [1] Women with PCOS have a 27 to 50% prevalence of anxiety disorders, roughly three times the general population rate. [7] If your first-visit intake form does not include a mental health screen, ask your provider to administer one.

What to Bring to the Appointment: A Practical Checklist

A short list makes the advice above actionable.

• A printed or digital menstrual calendar covering at least the past 3 months, with cycle lengths calculated
• A list of every medication, supplement, and hormonal contraceptive you currently take, including dose and duration
• Photographs documenting hirsutism or acne progression, dated if possible
• Any prior lab results (TSH, CBC, lipid panel, pelvic ultrasound reports)
• Family history notes: type 2 diabetes, early cardiovascular disease, irregular periods, or known PCOS in first-degree relatives
• Your written question list, organized by the four domains above
• Insurance card and prior authorization documentation if GLP-1s or fertility medications are being considered

Arriving with this material allows the clinician to spend appointment time on interpretation and treatment planning rather than history reconstruction.

After the First Visit: What to Expect Next

A well-structured first PCOS visit should end with a confirmed or working diagnosis, a completed or ordered lab panel, a documented treatment plan with specific targets (cycle regularity, weight goal, androgen threshold), and a scheduled follow-up at 8 to 12 weeks. If you leave without clear next steps, contact the office within 48 hours to request a written after-visit summary with those four elements.

Labs drawn at the first visit typically return within 3 to 7 business days. Ultrasound results, if ordered same-day, usually reach the chart within 24 to 48 hours. Follow-up at 3 months is standard after starting metformin, a COC, or a GLP-1 agonist; repeat testosterone, fasting insulin, and HbA1c at that visit provides the first objective signal of treatment response. [1]

The Endocrine Society guideline states: "All women with PCOS should receive information about the long-term health implications of PCOS, including metabolic, cardiovascular, and oncologic risks, at the time of diagnosis." [4] Holding your provider to that standard from visit one protects your long-term health, not just your cycle.